Northrop Grumman raises 2026 outlook after 7% sales growth
Northrop Grumman raised third-quarter 2026 sales 7% to $11.1 billion and lifted its full-year outlook. Backlog reached $109.6 billion, the value of orders received but not yet delivered.
Key points
- Net earnings were $7.89 per share, compared with $7.67 a year earlier.
- The company raised its 2026 adjusted earnings per share guidance, which excludes pension mark-to-market effects, to $29.35 to $29.75 from $28.60 to $29.10.
- The company previously recognized about $2.0 billion of losses on the B-21's low-rate initial production phase.
Sales grew in all four segments
Net earnings were $7.89 per share, compared with $7.67 a year earlier. New orders for the quarter totaled $16.4 billion.
Aeronautics Systems grew fastest, up 14% on the F-35, B-21 bombers and B-2 sustainment. Defense Systems grew 12%, mainly on the Sentinel missile program.
The operating margin fell to 11.4% from 11.9%. The company attributes this mainly to a $52 million decline in a pension accounting adjustment.
Northrop Grumman: key third-quarter 2026 figures
Revenue by quarter, $B
Sector context: 55 covered companies in Industrials reported a median revenue change of +11.9% YoY in their latest filings.
New outlook
The company raised its 2026 adjusted earnings per share guidance, which excludes pension mark-to-market effects, to $29.35 to $29.75 from $28.60 to $29.10.
Kathy Warden, chair and chief executive officer, said the record backlog and investments will drive sales and earnings growth.
The B-21 bomber remains a risk
The company previously recognized about $2.0 billion of losses on the B-21's low-rate initial production phase. It made no significant change to that estimate this quarter, but warns that changes in the cost to complete the aircraft could materially affect results.
Stopgap U.S. government funding runs only until December 11, 2026. A prolonged government shutdown could disrupt programs and payments.
What to watch
In the annual report for 2026, check whether adjusted earnings per share reaches the $29.35 to $29.75 guidance. The second question is whether the B-21 loss estimate changes.
Original sources
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Northrop Grumman
A notification in your browser or on your phone when we publish about Northrop Grumman. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
